[Atherosclerosis and prostaglandins: new biochemical frontiers of a more rational therapy].
D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism; D004032:Diet; D011464:Epoprostenol / Q000378:metabolism; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008297:Male; D010204:Pantetheine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism*; D012306:Risk; D013931:Thromboxanes / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D008074:Lipoproteins; D011453:Prostaglandins; D013931:Thromboxanes; D014280:Triglycerides; D010204:Pantetheine; C005425:pantethine; D002784:Cholesterol; D011464:Epoprostenol; D011451:Prostaglandin-Endoperoxide Synthases
Aterosclerosi e prostaglandine: nuove frontiere biochimiche per una terapia più razionale.